Upconversion Nanoparticles for Cancer Therapy
Lanthanide‐doped upconversion nanoparticles (UCNPs) are anti‐Stokes emitters, which can produce higher‐energy ultraviolet/visible and near‐infrared (NIR) luminescence when excited with low‐energy NIR light. They are featured with nonphotobleaching, sharp emission peaks, superstability, low toxicity,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-VCH
2022-12-01
|
| Series: | Advanced NanoBiomed Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/anbr.202200092 |
| _version_ | 1828171705405669376 |
|---|---|
| author | Yang Li Guanying Chen |
| author_facet | Yang Li Guanying Chen |
| author_sort | Yang Li |
| collection | DOAJ |
| description | Lanthanide‐doped upconversion nanoparticles (UCNPs) are anti‐Stokes emitters, which can produce higher‐energy ultraviolet/visible and near‐infrared (NIR) luminescence when excited with low‐energy NIR light. They are featured with nonphotobleaching, sharp emission peaks, superstability, low toxicity, low imaging background, and functional multimodality. These characteristics endow them to be useful as nanoprobes for diagnostic applications and imaging‐guided cancer therapy. Importantly, the ability to convert tissue‐penetrating NIR light into visible and ultraviolet range can expedite Fenton‐ or Fenton‐based processes in chemical dynamic therapy (CDT), activate photosensitizers (PSs) to produce singlet oxygen in photodynamic therapy (PDT), and regulate light‐controlled drug delivery processes for efficacious cancer therapy. The past decade witnessed fast progress of UCNPs as agents in single‐mode therapy or combined therapies in the forefront researches on fighting cancer. This review summarizes the fundamental roles of UCNPs in cancer therapy, highlights types of cell deaths induced by excessive reactive oxygen species (ROS), and showcases cutting‐edge applications in combined cancer therapies as well as imaging‐guided cancer therapy. Challenges and outlook on the use of UCNPs for future directions in cancer therapy are also discussed. |
| first_indexed | 2024-04-12T03:29:27Z |
| format | Article |
| id | doaj.art-504a81c5353144918d42f9fbdd08540e |
| institution | Directory Open Access Journal |
| issn | 2699-9307 |
| language | English |
| last_indexed | 2024-04-12T03:29:27Z |
| publishDate | 2022-12-01 |
| publisher | Wiley-VCH |
| record_format | Article |
| series | Advanced NanoBiomed Research |
| spelling | doaj.art-504a81c5353144918d42f9fbdd08540e2022-12-22T03:49:35ZengWiley-VCHAdvanced NanoBiomed Research2699-93072022-12-01212n/an/a10.1002/anbr.202200092Upconversion Nanoparticles for Cancer TherapyYang Li0Guanying Chen1School of Chemistry and Chemical Engineering Harbin Institute of Technology Harbin 150001 ChinaSchool of Chemistry and Chemical Engineering Harbin Institute of Technology Harbin 150001 ChinaLanthanide‐doped upconversion nanoparticles (UCNPs) are anti‐Stokes emitters, which can produce higher‐energy ultraviolet/visible and near‐infrared (NIR) luminescence when excited with low‐energy NIR light. They are featured with nonphotobleaching, sharp emission peaks, superstability, low toxicity, low imaging background, and functional multimodality. These characteristics endow them to be useful as nanoprobes for diagnostic applications and imaging‐guided cancer therapy. Importantly, the ability to convert tissue‐penetrating NIR light into visible and ultraviolet range can expedite Fenton‐ or Fenton‐based processes in chemical dynamic therapy (CDT), activate photosensitizers (PSs) to produce singlet oxygen in photodynamic therapy (PDT), and regulate light‐controlled drug delivery processes for efficacious cancer therapy. The past decade witnessed fast progress of UCNPs as agents in single‐mode therapy or combined therapies in the forefront researches on fighting cancer. This review summarizes the fundamental roles of UCNPs in cancer therapy, highlights types of cell deaths induced by excessive reactive oxygen species (ROS), and showcases cutting‐edge applications in combined cancer therapies as well as imaging‐guided cancer therapy. Challenges and outlook on the use of UCNPs for future directions in cancer therapy are also discussed.https://doi.org/10.1002/anbr.202200092cancer therapiesmultimodal imagingreactive oxygen speciesupconversion nanoparticles |
| spellingShingle | Yang Li Guanying Chen Upconversion Nanoparticles for Cancer Therapy Advanced NanoBiomed Research cancer therapies multimodal imaging reactive oxygen species upconversion nanoparticles |
| title | Upconversion Nanoparticles for Cancer Therapy |
| title_full | Upconversion Nanoparticles for Cancer Therapy |
| title_fullStr | Upconversion Nanoparticles for Cancer Therapy |
| title_full_unstemmed | Upconversion Nanoparticles for Cancer Therapy |
| title_short | Upconversion Nanoparticles for Cancer Therapy |
| title_sort | upconversion nanoparticles for cancer therapy |
| topic | cancer therapies multimodal imaging reactive oxygen species upconversion nanoparticles |
| url | https://doi.org/10.1002/anbr.202200092 |
| work_keys_str_mv | AT yangli upconversionnanoparticlesforcancertherapy AT guanyingchen upconversionnanoparticlesforcancertherapy |